Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume 19, Issue 4, Pages 417-426Publisher
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10238-019-00571-w
Keywords
Cancer; Lung; Radiation pneumonitis; Fibrosis; Radiation; Therapy
Categories
Funding
- Innovation and Entrepreneurship Talent Project of Lanzhou [2018-RC-81]
- National Natural Science Foundation of China [81560508, 51563022]
- Fundamental Research Funds for the Central Universities [31920180020]
Ask authors/readers for more resources
Cancer research has advanced throughout the years with respect to the personalization of the treatments and to targeting cancer-related molecular signatures on different organs. Still, the adverse events of the treatments such as radiotherapy are of high concern as they may increase the mortality rate due to their severity. With the improved efficiency of cancer treatments, patient survival has been increasing. Consequently, the number of patients with adverse effects from radiotherapy is also expected to increase in the forthcoming years. Therefore, approaches for personalized treatments include the elimination of adverse events and decreasing the toxicity in healthy tissues while increasing the efficiency of cancer cytotoxicity. In this context, this paper aims to discuss the recent advances in the field of thorax irradiation therapy and its related toxicities leading to radiation pneumonitis in cancer patients. Molecular mechanisms involved in the radiation-induced lung injury and approaches used to overcome this lung injury are discussed. The discourse covers approaches such as therapeutic administration of natural products, current and prospective radioprotective drugs, and applications of mesenchymal stem cells for radiation-induced lung injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available